Background/Aim: Recent studies reported that lipopolysaccharide (LPS) exhibits beneficial effects on prevention of immune-related diseases by activating macrophages. We previously demonstrated that pre-treatment with LPS derived from Pantoea agglomerans (LPSp) activated amyloid (A) phagocytosis in mouse primary microglia. In the present study, we further examined the promotory effect on phagocytosis of phagocytic particles in the C8-B4 microglia cell line. Materials and Methods: Phagocytic analysis of C8-B4 cells was evaluated using phagocytic particles (latex beads or HiLyte™ Fluor 488-conjugated A1-42). Results: The phagocytic activity of latex beads was dependent on the concentration of beads and incubation time. LPSp, at as low as 100 pg/ml, significantly increased phagocytosis against the beads. In the experiment of A1-42 phagocytosis, LPSp significantly increased A phagocytic activity. Conclusion: LPSp treatment was confirmed to enhance A1-42 phagocytosis by mouse microglia. It is suggested that the use of LPSp may be a potential promising candidate for the prevention of Alzheimer's disease.
CITATION STYLE
Kobayashi, Y., Inagawa, H., Kohchi, C., Okazaki, K., Zhang, R., Kobara, H., … Soma, G. I. (2017). Lipopolysaccharides derived from pantoea agglomerans can promote the phagocytic activity of amyloid in mouse microglial cells. Anticancer Research, 37(7), 3917–3920. https://doi.org/10.21873/anticanres.11774
Mendeley helps you to discover research relevant for your work.